Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) yesterday and set a price target of ...

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

Stocks of several pharmaceutical companies slipped on Tuesday due to uncertainty surrounding Trump’s proposed tariffs on imported pharmaceutical products that were expected to be implemented from ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...

We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...

Read more on 2 durable dividend stocks that offer higher yields and strong cash flows, outperforming the S&P 500 in value, ...

AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks. Merck (NYSE:MRK) recently presented promising results ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.